In HRD mouse models, SPP1 blockade restored PARPi sensitivity, reversed acquired resistance, and enhanced T cell cytotoxicity-effects abrogated in immunodeficient mice, confirming immune dependence. Here, SPP1 is linked to hypoparathyroidism-retardation-dysmorphism syndrome.